US Patent Issued to CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) on July 1 for "BRD4 inhibitor compound in solid form and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,620, issued on July 1, was assigned to CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) Co. LTD. (Shijiazhuang, China).

"BRD4 inhibitor compound in solid form and preparation method therefor and use thereof" was invented by Chunli Shen (Shanghai), Yong Liu (Shanghai), Huanyu Bian (Shanghai), Chengde Wu (Shanghai) and Jiahu Wu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a solid form and a crystal form of a compound represented by formula (I) used as a BRD4 inhibitor, a preparation method therefor, and an application thereof in the preparation of a medicine for treating BRD4-related diseases. (I)."

The patent was filed ...